HC ADVISORS, LLC – Eli Lilly and Company Transaction History
HC ADVISORS, LLC portfolio value:
$1.45M
portfolio value
HC ADVISORS, LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -4K | $323.35 | 4.50K | |
| Q2 2022 | share | Decrease | -7.46% | -363 shares | 66K | $324.23 | 4.50K |
| Q1 2022 | share | 0.00% | 0 shares | 50K | $286.37 | 4.86K | |
| Q4 2021 | share | Increase | +0.08% | 4 shares | 220K | $277.25 | 4.86K |
| Q3 2021 | share | Increase | +48.81% | 1.59K shares | 374K | $230.3 | 4.86K |
| Q2 2021 | share | Increase | 0.00% | 3.26K shares | 750K | $228.04 | 3.26K |
| Q3 2020 | share | Decrease | -100.00% | -9.40K shares | -1.54M | $145.05 | 0 |
| Q2 2020 | share | Increase | 0.00% | 9.40K shares | 1.54M | $160.1 | 9.40K |
| Q1 2020 | share | Decrease | -100.00% | -9.63K shares | -1.26M | $134.64 | 0 |
| Q4 2019 | share | Increase | 0.00% | 9.63K shares | 1.26M | $126.91 | 9.63K |